Evidence map›Paper›PMID 40613603›Full record

ArticleJournal of medical Internet research2025

Building an Ethical Framework for European Pharmacists in e-Pharmacies.

Alexandra Toma, Ofelia Crişan

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alexandra Toma *Department of Pharmaceutical Legislation and Management, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0003-3032-0374
Ofelia Crişan *Department of Pharmaceutical Legislation and Management, Faculty of Pharmacy, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0003-0936-6175

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients using e-pharmacies benefit substantially from their privacy and accessibility; however, they must also be aware of the health and safety risks. These risks can be mitigated through the implementation of robust legal and ethical frameworks. European pharmacists working in e-pharmacies are obligated to respect the legal frameworks governing the remote sale of medicines, as well as the rules of professional ethics, while considering the unique benefits and challenges of establishing online therapeutic relationships with patients. This Viewpoint paper aims to propose a comprehensive ethical framework for European pharmacists in e-pharmacies that promotes consistency and ensures patient rights while fostering professional integrity and responsibility. To this end, the codes of ethics of pharmacists in the European Union (EU) member states were explored to determine the extent to which they address e-pharmacies and to begin from their provisions the building of a shared ethical framework, supported by previously published findings. The ethical guidance provided by professional associations and other competent authorities of European pharmacists varies significantly across member states. In most EU member states, pharmacists' codes of ethics do not contain rules addressing e-pharmacies. Only 8 EU member states have adopted rules guiding pharmacists' conduct in e-pharmacies, providing detailed regulations aimed at safeguarding patients' rights during the remote supply of medicines, health care products, and services. Considering these findings, the development of a common ethical framework for European pharmacists operating in e-pharmacies would be helpful for the development of ethics in their conduct on the internet. On the basis of the fundamental principles of biomedical ethics, we engaged in a reiterative process of reflection and discussion to develop an ethical framework tailored to the e-pharmacy context as our main contribution to knowledge. The proposed framework-representing a novel contribution to e-pharmacy ethics research-highlights ethical issues that should be incorporated into pharmacists' codes of ethics or dedicated guidelines. These issues range from ensuring patient autonomy in selecting e-pharmacies to showing solidarity in the global e-pharmacy environment. Its novelty could be a major input for advancing e-pharmacy ethics. The following key messages are intended for pharmacists and their professional associations or other competent authorities interested in this field. Pharmacists' codes of ethics should keep pace with the development of e-pharmacies to ensure they remain relevant and effective in guiding ethical conduct and decision-making in such an environment. Establishing a comprehensive, shared ethical framework for European pharmacists in e-pharmacies can foster a deeper understanding and appreciation of the opportunities afforded by emerging technologies. By facilitating the development of ethical conduct of pharmacists in e-pharmacies, such a framework can enhance patients' well-being while promoting fundamental principles of autonomy, equity, and solidarity in this evolving field.

Indexed as

Ethics, PharmacyInternetPharmacistsCodes of EthicsEuropeEuropean UnionHumansautonomycodes of ethicse-pharmacyethical frameworkhealthjusticemedicinespatients’ rightspharmacistssolidarity

Identifiers

PMID40613603
PMCPMC12274778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.